[1]
“Use of an Investigator’s Global Assessment Scale to Evaluate Disease Severity in Patients swith Epidermolysis Bullosa Simplex”, J of Skin, vol. 2, no. S1, p. S55, Feb. 2018, doi: 10.25251/skin.2.supp.55.